0
0
10/30/22 at 2:00pm
Organization
Medical Dialogues
Author
Dr Aditi Yadav
41 words
0
Comments
USA: A study suggested the safety of Candesartan among non-hypertensive prodromal Alzheimer's disease individuals. The researchers advocated its role in decreasing brain amyloid biomarkers,...
You are the first to view
https://medicaldialogues.in/neurology-neurosurgery/bp-drug-candesartan-lowers-amyloid-deposition-and-improves-cognition-in-alzheimers-patients-101398
Create an account
or login to join the discussion